Dexcom, a company specializing in continuous glucose monitoring technology, said it recently identified certain lots of Dexcom G7 sensors originally designated as scrap and intended for destruction that were stolen during the destruction process, then sold by third parties.
Scrapping limited amounts of sensors that do not meet Dexcom standards is a routine part of the company’s quality control process. Sensors identified as scrap are sent to a third-party vendor for destruction and recycling.
At this time, Dexcom has identified two lots of Dexcom G7 sensors (1725204004 and 1725069002) that were stolen, sold and used by some customers.
“Nothing matters more to Dexcom than the safety of our users and maintaining the trust of the diabetes community,” said Dexcom CEO Jake Leach in a statement. “We are treating this matter with the utmost seriousness and are working closely with regulators and other authorities to ensure user safety, determine exactly how this product was stolen and hold the perpetrators fully accountable for their crimes.”
Dexcom traced sales of this stolen product back to Pharmsource, who is not an authorized Dexcom distributor but supplies some independent pharmacies and DME distributors in the United States. The company warned pharmacies that purchased product from Pharmsource to take extra care to review their inventory.
Dexcom said it is notifying customers directly across numerous communication channels. This issue primarily impacts the U.S., therefore communication to U.S. customers will precede communication to international customers.
Users with sensors from affected Dexcom G7 lots (1725204004 and 1725069002) should not use those sensors and can call Dexcom Customer Support in the U.S. at 1-844-478-1600 to request replacements. More information on how to determine if sensors are from an affected lot and what action to take is available at www.dexcom.com/theft-check. Dexcom is working to update this website with resources for users outside the U.S. and will notify those users as soon as it is updated.
Potential harm associated with stolen product
Lot 1725204004: Dexcom G7 sensors that are not properly sterilized have an increased risk of skin infection.
Lot 1725069002: Dexcom G7 sensors from a lot with an elevated internal testing failure rate have an increased risk of having no sensor readings available.
There have been no reported severe adverse events associated with the stolen product.
